BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18177633)

  • 1. Beneficial effect of dipyridyl, a liposoluble iron chelator against focal cerebral ischemia: in vivo and in vitro evidence of protection of cerebral endothelial cells.
    Méthy D; Bertrand N; Prigent-Tessier A; Mossiat C; Stanimirovic D; Beley A; Marie C
    Brain Res; 2008 Feb; 1193():136-42. PubMed ID: 18177633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model.
    Demougeot C; Van Hoecke M; Bertrand N; Prigent-Tessier A; Mossiat C; Beley A; Marie C
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1080-7. PubMed ID: 15280435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic cell death progression after photothrombotic focal cerebral ischaemia: effects of the lipophilic iron chelator 2,2'-dipyridyl.
    Van Hoecke M; Prigent-Tessier A; Bertrand N; Prevotat L; Marie C; Beley A
    Eur J Neurosci; 2005 Sep; 22(5):1045-56. PubMed ID: 16176346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
    Horky LL; Pluta RM; Boock RJ; Oldfield EH
    J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells.
    Koo SW; Casper KA; Otto KB; Gira AK; Swerlick RA
    J Invest Dermatol; 2003 May; 120(5):871-9. PubMed ID: 12713595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.
    Wu H; Wu T; Li M; Wang J
    Neurobiol Dis; 2012 Jan; 45(1):388-94. PubMed ID: 21930208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke.
    Millerot-Serrurot E; Bertrand N; Mossiat C; Faure P; Prigent-Tessier A; Garnier P; Bejot Y; Giroud M; Beley A; Marie C
    Neurochem Int; 2008 Jun; 52(8):1442-8. PubMed ID: 18485533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats.
    Meng F; Liu R; Gao M; Wang Y; Yu X; Xuan Z; Sun J; Yang F; Wu C; Du G
    Brain Res; 2011 May; 1391():93-101. PubMed ID: 21435338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferrous iron chelator to treat subarachnoid haemorrhage.
    Fricker J
    Mol Med Today; 1997 Jun; 3(6):232. PubMed ID: 9211408
    [No Abstract]   [Full Text] [Related]  

  • 10. 2,2'-dipyridyl induces pexophagy.
    Jin A; Lee JN; Kim MS; Kwak S; Kim SJ; Song K; Choe SK; Park R
    Biochem Biophys Res Commun; 2016 Jan; 469(4):941-7. PubMed ID: 26721431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Fe
    Imai T; Iwata S; Hirayama T; Nagasawa H; Nakamura S; Shimazawa M; Hara H
    Sci Rep; 2019 Apr; 9(1):6228. PubMed ID: 30996325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury.
    Demougeot C; Garnier P; Mossiat C; Bertrand N; Giroud M; Beley A; Marie C
    J Neurochem; 2001 Apr; 77(2):408-15. PubMed ID: 11299303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage.
    Jiang J; Wang W; Sun YJ; Hu M; Li F; Zhu DY
    Eur J Pharmacol; 2007 Apr; 561(1-3):54-62. PubMed ID: 17303117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ASK1 on vascular permeability and edema formation in cerebral ischemia.
    Song J; Cheon SY; Lee WT; Park KA; Lee JE
    Brain Res; 2015 Jan; 1595():143-55. PubMed ID: 25446452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 6 is essential for sodium sulfide-mediated cytoprotective effect in ischemia/reperfusion-stimulated brain endothelial cells.
    Hu Y; Li R; Yang H; Luo H; Chen Z
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):601-9. PubMed ID: 25543188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease.
    Wang N; Jin X; Guo D; Tong G; Zhu X
    Biomacromolecules; 2017 Feb; 18(2):461-474. PubMed ID: 27989126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.
    Kahles T; Luedike P; Endres M; Galla HJ; Steinmetz H; Busse R; Neumann-Haefelin T; Brandes RP
    Stroke; 2007 Nov; 38(11):3000-6. PubMed ID: 17916764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Neurol Res; 2008 Apr; 30(3):288-93. PubMed ID: 17767813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
    Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
    J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calycosin-7-O-β-D-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury.
    Fu S; Gu Y; Jiang JQ; Chen X; Xu M; Chen X; Shen J
    J Ethnopharmacol; 2014 Aug; 155(1):692-701. PubMed ID: 24930357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.